{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T14:40:53Z","timestamp":1710945653726},"reference-count":4,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anaesthesiologie"],"DOI":"10.1007\/s00101-022-01244-2","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T12:04:07Z","timestamp":1672833847000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dexmedetomidin zur Sedierung kritisch Kranker in der Intensivmedizin"],"prefix":"10.1007","author":[{"given":"Thomas","family":"Saller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludwig","family":"Ney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,4]]},"reference":[{"key":"1244_CR1","unstructured":"Rote Hand Brief \u201eDexmedetomidin: Risiko von erh\u00f6hter Mortalit\u00e4t bei Intensivpatienten \u2264 65\u00a0Jahren\u201c vom 15.06.2022. https:\/\/www.bfarm.de\/SharedDocs\/Risikoinformationen\/Pharmakovigilanz\/DE\/RHB\/2022\/rhb-dexmedetomidin.html#:~:text=Die%20Anwendung%20von%20Dexmedetomidin%20war,mit%20einem%20h%C3%B6heren%20Mortalit%C3%A4tsrisiko%20assoziiert. Zugegriffen: 30. Aug. 2022"},{"key":"1244_CR2","unstructured":"(2020) AWMF, S3-Leitlinie \u201eAnalgesie, Sedierung und Delirmanagement in der Intensivmedizin\u201c. https:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/001-012l_S3_Analgesie-Sedierung-Delirmanagement-in-der-Intensivmedizin-DAS_2021-08.pdf. Zugegriffen: 18. Okt. 2022"},{"key":"1244_CR3","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202206-1208OC","author":"Y Shehabi","year":"2022","unstructured":"Shehabi\u00a0Y, Serpa Neto\u00a0A, Bellomo\u00a0R et al (2022) SPICE III study investigators. Dexmedetomidine and propofol sedation in critically Ill patients and dose associated 90-day mortality: a secondary cohort analysis of a\u00a0randomized controlled trial (SPICE-III). Am J Respir Crit Care Med. https:\/\/doi.org\/10.1164\/rccm.202206-1208OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"1244_CR4","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.bja.2022.06.020","volume":"129","author":"K Heybati","year":"2022","unstructured":"Heybati\u00a0K, Zhou\u00a0F, Ali\u00a0S et al (2022) Outcomes of dexmedetomidine versus propofol sedation in critically ill adults requiring mechanical ventilation: a\u00a0systematic review and meta-analysis of randomised controlled trials. Br J Anaesth 129(4):515\u2013526. https:\/\/doi.org\/10.1016\/j.bja.2022.06.020","journal-title":"Br J Anaesth"}],"container-title":["Die Anaesthesiologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-022-01244-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00101-022-01244-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-022-01244-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T12:04:12Z","timestamp":1672833852000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00101-022-01244-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":4,"alternative-id":["1244"],"URL":"https:\/\/doi.org\/10.1007\/s00101-022-01244-2","relation":{},"ISSN":["2731-6858","2731-6866"],"issn-type":[{"value":"2731-6858","type":"print"},{"value":"2731-6866","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,4]]},"assertion":[{"value":"14 December 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.\u00a0Saller und L.\u00a0Ney geben an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}